HRES 928
Affirming support for most-favored-Nation drug pricing for United States patients.
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 12:16 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This resolution expresses support for ensuring that U.S. patients pay no more for prescription drugs than patients in other developed countries. It highlights the high cost of prescription drugs in the United States compared to other nations, citing data on spending and patient choices due to cost. The resolution affirms the goal of aligning U.S. drug prices with those paid elsewhere and supports policies like Medicare drug price negotiation and increased competition to make medications more affordable for all Americans.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.